Certara Inc (NAS:CERT)

$ 10.61 -0.41 (-3.72%) Market Cap: 1.71 Bil Enterprise Value: 1.78 Bil PE Ratio: 0 PB Ratio: 1.62 GF Score: 73/100

Q3 2024 Certara Inc Earnings Call Transcript
Nov 06, 2024

$10.91 (+5.82%)

Earnings
Q2 2024 Certara Inc Earnings Call Transcript
Aug 06, 2024

$15.08 (+1.14%)

Earnings
Q1 2024 Certara Inc Earnings Call Transcript
May 07, 2024

$17.66 (+0.11%)

Earnings
Q4 2023 Certara Inc Earnings Call Transcript
Feb 29, 2024

$16.88 (-0.59%)

Earnings
Certara Inc at Stephens Investment Conference Transcript
Nov 15, 2023
Q3 2023 Certara Inc Earnings Call Transcript
Nov 08, 2023

$12.48 (-0.79%)

Earnings
Certara Inc at Robert W Baird Global Healthcare Conference Transcript
Sep 13, 2023
Certara Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2023
Q2 2023 Certara Inc Earnings Call Transcript
Aug 09, 2023

$17.92 (-2.56%)

Earnings
Certara Inc at Jefferies Healthcare Conference Transcript
Jun 07, 2023
Certara Inc at Bank of America Global Healthcare Conference Transcript
May 10, 2023
Q1 2023 Certara Inc Earnings Call Transcript
May 08, 2023

$23.42 (+1.34%)

Earnings
Certara Inc at Barclays Global Healthcare Conference Transcript
Mar 15, 2023
Q4 2022 Certara Inc Earnings Call Transcript
Mar 01, 2023

$18.44 (+1.77%)

Earnings
Certara Inc at Stephens Investment Conference Transcript
Nov 17, 2022
Certara Inc at Jefferies London Healthcare Conference Transcript
Nov 15, 2022
Q3 2022 Certara Inc Earnings Call Transcript
Nov 07, 2022

$12.74 (+19.58%)

Earnings
Certara Inc at Robert W Baird Global Healthcare Conference Transcript
Sep 14, 2022
Certara Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022
Q2 2022 Certara Inc Earnings Call Transcript
Aug 09, 2022

$22.84 (-5.35%)

Earnings
Certara Inc at William Blair Growth Stock Conference Transcript
Jun 09, 2022
Certara Inc at Jefferies Healthcare Conference Transcript
Jun 08, 2022
Certara Inc at Citi Biopharma Co-Panel Day (Virtual) Transcript
May 18, 2022
Certara Inc at Bank of America Healthcare Conference Transcript
May 10, 2022
Q1 2022 Certara Inc Earnings Call Transcript
May 05, 2022

$18.69 (-4.84%)

Earnings
Q4 2021 Certara Inc Earnings Call Transcript
Mar 01, 2022

$24.66 (-2.68%)

Earnings
Certara Inc Investor Day Transcript
Dec 15, 2021
Certara Inc at Piper Sandler Healthcare Conference (Virtual) Transcript
Nov 22, 2021
Q3 2021 Certara Inc Earnings Call Transcript
Nov 09, 2021

$41.72 (-0.81%)

Earnings
Certara Inc at Bank of America Tech Solutions for Drug Discovery Conference (Virtual) Transcript
Sep 20, 2021
Certara Inc at Robert W Baird Global Healthcare Conference (Virtual) Transcript
Sep 15, 2021
Certara Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 14, 2021
Q2 2021 Certara Inc Earnings Call Transcript
Aug 05, 2021

$27.99 (+0.25%)

Earnings
Certara Inc at Jefferies Healthcare Conference (Virtual) Transcript
Jun 04, 2021
Certara Inc at William Blair Growth Stock Conference (Virtual) Transcript
Jun 01, 2021
Certara Inc Annual Shareholders Meeting Transcript
May 18, 2021
Certara Inc at Bank of America Securities 2021 Virtual Health Care Conference (Virtual) Transcript
May 11, 2021
Q1 2021 Certara Inc Earnings Call Transcript
May 06, 2021

$29.38 (-6.40%)

Earnings
Q4 2020 Certara Inc Earnings Call Transcript
Mar 04, 2021

$30.52 (-10.00%)

Earnings

Q4 2022 Certara Inc Earnings Call Transcript

Mar 01, 2023 / 10:00PM GMT

Release Date Price: $18.44 (+1.77%)

Transcript 10-K8-K

Operator

Good day, and thank you for standing by. Welcome to the Certara Fourth Quarter 2022 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, David Deuchler, Investor Relations. Please go ahead.

David J. Deuchler

Gilmartin Group LLC - MD

Good afternoon, everyone. Thank you all for participating in today's conference call. On the call from Certara, we have William Feehery, Chief Executive Officer; and Andrew Shimek, Chief Financial Officer.

Earlier today, Certara released financial results for the quarter ended December 31, 2022. A copy of the press release is available on the company's website.

Before we begin, I would like to remind you that management will make statements during this call that will include forward-looking statements, and actual results may differ materially from those expressed or implied in the forward-looking statements. Please refer to Slide 2 in the accompanying materials for additional

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.